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Center, 9 Avenue de Champel, 1211 Geneva 4, Switzerland and the efficiency with which at least some types of lesions3GMBC, Universite´ Louis Pasteur, 1 Rue Laurent Fries, BP163,
are removed in different parts of the genome. Apart67404, Illrich Ce´dex, France
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accessibility of the DNA for repair proteins (Smerdon andEN6 3LD, UK
Thoma, 1990; Brouwer et al., 1992), a clear link exists4Corresponding author
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Bohr et al. (1985) were the first to show that active RNA
A.J.van Gool and E.Citterio contributed equally to this work polymerase II-transcribed genes are repaired, at least for
a number of lesions, with a higher efficiency than theTranscription-coupled repair (TCR), a subpathway of genome overall. Interestingly, it turned out that this tran-nucleotide excision repair (NER) defective in Cockayne scription-coupled DNA repair (TCR) pathway enhancessyndrome A and B (CSA and CSB), is responsible for
only the repair of the transcribed strand of active genes,the preferential removal of DNA lesions from the
while the non-transcribed strand is repaired at a slower rate,transcribed strand of active genes, permitting rapid
similar to that of the global genome (Mellon et al., 1987).resumption of blocked transcription. Here we demon-
Cells derived from Cockayne syndrome (CS) patientsstrate by microinjection of antibodies against CSB and
display a selective defect in the TCR pathway, whileCSA gene products into living primary fibroblasts, that
global genome repair is unaffected (Venema et al., 1990a;both proteins are required for TCR and for recovery
Van Hoffen et al., 1993). This strongly suggests that theof RNA synthesis after UV damage in vivo but not for
two CS genes, CSA and CSB, are required for TCR. Inbasal transcription itself. Furthermore, immunodeple-
support of this concept, we found that disruption of thetion showed that CSB is not required for in vitro NER
Saccharomyces cerevisiae (Van Gool et al., 1994) andor transcription. Its central role in TCR suggests that
mouse (Van der Horst et al., 1997) homologues of CSBCSB interacts with other repair and transcription
results in impairment of TCR. A suggested model for theproteins. Gel filtration of repair- and transcription-
TCR reaction (Mellon et al., 1987) involves lesion detec-competent whole cell extracts provided evidence that
tion by a transcribing RNA polymerase that is stalledCSB and CSA are part of large complexes of different
because of the presence of DNA injury. Subsequently, thesizes. Unexpectedly, there was no detectable association
CSA and CSB proteins are thought to permit access toof CSB with several candidate NER and transcription
the damage by inducing either retraction (Hanawalt, 1992)proteins. However, a minor but significant portion (10–
or dissociation of the blocked RNA polymerase. Simul-15%) of RNA polymerase II was found to be tightly
taneously, they may recruit the NER machinery, thusassociated with CSB. We conclude that within cell-free
accomplishing the fast repair of the lesion and rapidextracts, CSB is not stably associated with the majority
resumption of the vital process of transcription (Troelstraof core NER or transcription components, but is part
et al., 1992; Hanawalt et al., 1994). The presence of theof a distinct complex involving RNA polymerase II.
Swi2/Snf2-like ATPase domain in CSB is intriguing inThese findings suggest that CSB is implicated in, but
this respect, since other members of the Swi2/Snf2 sub-not essential for, transcription, and support the idea
family have been shown to be able to remodel or disruptthat Cockayne syndrome is due to a combined repair
protein–DNA interactions (reviewed in Pazin andand transcription deficiency.
Kadonaga, 1997).Keywords: Cockayne syndrome/CSB/nucleotide excision
The clinical symptoms suggest that more processes thanrepair/RNApolymerase II/transcription-coupled repair
TCR alone are affected in CS, since a number of CS
features cannot be attributed easily to a sole repair impair-
ment. The consequences of a total NER deficiency areIntroduction
illustrated by xeroderma pigmentosum group A (XP-A)
patients, who show extreme sensitivity to sun (UV) light,Nucleotide excision repair (NER) is a universal and
verstatile DNA repair pathway capable of removing a pigmentation abnormalities and a high predisposition to
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develop skin cancer in sun-exposed areas. In addition,
frequently accelerated neurodegeneration is observed
(Bootsma et al., 1997). Despite the fact that the NER
defect in CS patients is only partial, the syndrome displays
many extra and more severe symptoms than the totally
deficient XP-A individuals. CS shares increased photo-
sensitivity with XP, but is in addition associated with
seriously impaired physical and sexual development, and
severe neurological abnormalities including mental retard-
ation, spasticity, deafness and patchy demyelination of
neurons (Nance and Berry, 1992; Bootsma et al., 1997).
Patients with CS features combined with XP have been
found in XP groups B and D, which carry mutations in
TFIIH, a multi-subunit factor involved in both NER and
basal transcription (Vermeulen et al., 1994). The origin
of many of the CS features was postulated to be due to a
subtle defect in transcription rather than in the repair
function of the TFIIH complex, affecting the expression
of a specific set of genes (Vermeulen et al., 1994).
Following this reasoning, CSA and CSB could also fulfil
a (non-essential) role in the transcription process itself
in addition to mediating transcription–repair coupling
(discussed in Van Gool et al., 1997). Here we present a
characterization of the function of CSB in repair and
transcription, including an analysis of proteins associated Fig. 1. Characterization of anti-CSB and anti-CSA antibodies.
with CSB. (A) Specificity of the anti-CSB serum. Immunoblots of HeLa or CS-B
(CS1AN-Sv) WCEs were incubated with: crude anti-CSB serum (lanes
1 and 3), crude anti-CSB serum pre-incubated with GST–CSB fusion
Results protein (lane 2) and affinity-purified anti-CSB serum (lane 4). The
molecular weight of pre-stained marker proteins is indicated. (B) The
Characterization of polyclonal anti-CSB and anti-CSB antiserum immunoprecipitates in vitro translated CSB
protein. In vitro translated CSB (lane 5) was incubated with eitheranti-CSA antibodies
crude anti-CSB serum (lane 6) or pre-immune serum (lane 7) andThe crude anti-CSB serum reacted with several proteins
binding to protein A beads was analysed on SDS–PAGE.in immunoblot analysis of a HeLa whole cell extract
(C) Specificity of the anti-CSA antiserum. An immunoblot of 2 ng of
(WCE), among which was a 168 kDa protein (Figure 1, the GST–CSA fusion protein (lane 8), and 10 μg of HeLa (lane 9) or
lane 1). This represents the CSB protein, because: (i) it CS3BE-Sv (CS-A) (lane 10) WCE was incubated with affinity-purified
anti-CSA antiserum. On the same gel, in vitro translated CSA proteinhas the predicted molecular weight and co-migrates with
was analysed (lane 11). Note that the serum cross-reacts with otherin vitro translated CSB protein; (ii) the antiserum immuno-
cellular proteins. (D) Overexpression of CSB cDNA does not lead toprecipitates in vitro translated CSB (Figure 1B); (iii) the elevated protein levels. A WCE of CS1AN-Sv cells transfected with
immunoreaction with the 168 kDa protein can be competed the tagged CSB cDNA (2tCSB), under control of the SV40 promoter
(see below), is analysed on immunoblot with a HeLa WCE. (E) CSBfor specifically by pre-incubating the crude antiserum with
is specifically absent in CS-B WCE, but not in other repair-deficienta GST–CSB fusion protein (Figure 1, lane 2); (iv) the
extracts. Equal amounts (10 μg) of the indicated WCEs were analysedband is missing in a WCE derived from CS1AN-Sv cells
on immunoblots for the presence of CSB. The 80 kDa cross-reacting
that lack the C-terminal part (amino acids 337–1493) of band provides a convenient internal control on differences in protein
CSB (Troelstra et al., 1992) (Figure 1, lane 3) against loading.
which the antiserum was elicited, while the band reappears
when the cells are transfected with the (double-tagged)
CSB cDNA (Figure 1D, last lane); and (v) following nized several proteins in a HeLa WCE, among which was
one of 44 kDa (lane 9). This band is selectively absent inaffinity purification, the serum strongly stained the 168 kDa
protein (Figure 1, lane 4), while occasionally an 80 kDa an extract of CSA-deficient CS3BE-Sv cells (lane 10),
while the size matches in vitro translated CSA (lane 11),protein of unknown identity is recognized as well
(Figure 1D). indicating that the 44 kDa protein is CSA.
The affinity-purified CSB antiserum was used to screen
all known NER-deficient human complementation groups Intracellular localization of CSB
The presence of a consensus sequence for a nuclear(XP-E not tested). Apart from the CS-B WCE, all other
extracts contained comparable amounts of the CSB protein localization signal in CSB and its central role in TCR
predict that CSB is located in the nucleus. This was(Figure 1E), ruling out that mutations in other NER factors
indirectly affect the cellular level of CSB, in contrast to confirmed by immunofluorescence studies (Figure 2).
Although the gene is very weakly expressed (Troelstrawhat has been observed for, for example, the ERCC1/
XPF (Van Vuuren et al., 1995; Sijbers et al., 1996a) and et al., 1993), clear CSB staining was observed in the
nuclei, but not the cytoplasm, of HeLa cells (Figure 2A).XRCC1/ligase III (Caldecott et al., 1995) complexes.
The affinity-purified anti-CSA antiserum, strongly The CS1AN-Sv cells show no staining of CSB at all
(Figure 2A), confirming the immunoblot results shownreacting with a very low amount (2 ng) of GST–CSA
fusion protein on immunoblots (Figure 1, lane 8), recog- above. UV irradiation of HeLa cells, prior to fixation and
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Fig. 2. The CSB protein is localized in the nucleus. (A) The affinity-
purified anti-CSB antibody was used to stain the endogenous CSB
protein in HeLa or CS-B (CS1AN-Sv) cells. The left panel displays
the DAPI-stained chromosomal DNA, while the right panel depicts
CSB staining, visualized by FITC-conjugated secondary antibodies.
(B) CSB does not co-localize with chromatin during various stages of
mitosis. Indicated are prophase, metaphase, anaphase and telophase
(from left to right).
staining, did not alter the immunofluorescence pattern of
CSB (data not shown). Previously, the DNA repair com-
plex XPC/HHR23B was found to display an anaphase/
telophase-specific association with chromatin (Van der
Spek et al., 1996). In contrast, in the majority of metaphase
cells, CSB co-localizes with the microtubules of the
mitotic spindle, which mediate the segregation of the
chromosomes to the spindle poles (Figure 2A and B)
(Hyman, 1995). Fig. 3. Microinjection of anti-CSB and anti-CSA antisera inhibits
transcription-coupled repair but not transcription in vivo. XP-C
(XP21RO) fibroblasts were microinjected with anti-CSB (A) orFunction of the CSA and CSB proteins in vivo and
anti-CSA (B) antisera to assay the effect on TCR (visualized byin vitro
unscheduled DNA synthesis, UDS), or in wild-type (C5RO) fibroblastsTo gain more insight into the biological function of CSA to determine the effect on transcription levels (C). (A–C) show
and CSB in vivo, the specific antisera were microneedle micrographs of injected cells (indicated by an arrow) and uninjected
(surrounding mononuclear) cells, assayed for NER or transcription byinjected into living primary human fibroblasts and the
[3H]thymidine or [3H]uridine pulse labelling respectively, as describedeffects on TCR, transcription and RNA synthesis recovery
in Materials and methods. The fibroblast with the dark nucleus in (B)were analysed (Figure 3, Table I). Repair activity is
was in S-phase during the [3H]thymidine incubation. The
reflected by the level of UV-induced unscheduled DNA quantification of the microinjections is shown in Table I.
synthesis (UDS), determined by [3H]thymidine incorpor-
ation after UV exposure, whereas transcription levels
were quantitated by pulse labelling with [3H]uridine (Van Therefore, to analyse the effect on TCR, we used XP-C
fibroblasts for microinjection. Two independent CSA anti-Vuuren et al., 1994; Vermeulen et al., 1994) (see Materials
and methods). The contribution of TCR to total repair sera appeared to inhibit the residual UDS of XP-C
fibroblasts (which is 10% of repair-competent cells ana-synthesis (measured as UDS 2 h after UV exposure) is
small, because most repair synthesis is derived from the lysed in parallel) by a factor of 2–2.5, while the pre-
immune serum had no effect (Figure 3B, Table I). Moreglobal genome repair subpathway, particularly from the
efficient removal of UV-induced 6/4 photoproducts. This dramatically, microinjection of two anti-CSB antisera
reduced the residual UDS of injected XP-C cells to 15–is apparent from the low residual UDS in XP-C cells, that
are defective in global genome repair and only perform 22% of the levels in uninjected XP-C fibroblasts (Figure
3A, Table I).TCR (Venema et al., 1990b; Carreau and Hunting, 1992).
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Table I. Effect of CSA and CSB antibody injection on TCR, recovery
of RNA synthesis and transcription
Injected % Residual % Recovery of % Transcription
antiserum UDS XP-Ca RNA synthesisb
None 100 100 100
Pre-immune 100 95 –
Anti-CSA (#1) 47 – 109
Anti-CSA (#2) 40 65 104
Anti-CSB (#1) 22 – 105
Anti-CSB (#2) 15 61 99
Wild-type and XP-C fibroblasts were microinjected with anti-CSA and
anti-CSB antisera as explained in Figure 3. Percentages are calculated
by comparing injected versus uninjected cells on the same slide, with
a typical SEM of 5%. ‘#1’ and ‘#2’ are independent antisera.
a100% corresponds to 19 grains, which represents 10% of the UDS
observed in wild-type cells that were treated in parallel.
bRecovery of RNA synthesis is defined by the ratio of transcription
Fig. 4. Complete CSB immunodepletion has no significant effect onlevels in UV-irradiated wild-type cells relative to unirradiated cells. In
in vitro repair and basal transcription. A repair-proficient HeLa WCEwild-type cells, RNA synthesis at 24 h post-UV had recovered to 70%
was immunodepleted using crude anti-CSB serum under lowof that of untreated cells. This value is set at 100%. CS1AN-Sv
stringency (buffer A) conditions. Complete CSB depletion from the(CS-B) cells that were included in the experiment displayed a recovery
extract, and binding to the beads was verified by immunoblotting ofof 13%, relative to wild-type values.
10 μg of (non-)depleted extract (top panel). Exactly equal amounts–: not determined.
(100 μg) of non-depleted and depleted HeLa extract were tested in the
in vitro repair (middle panel) and in vitro transcription (bottom panel)
A hallmark of CS cells is the failure to recover RNA assays. Immunodepletion using the pre-immune serum did not
precipitate the CSB protein and, consequently, this had no effect onsynthesis after UV irradiation, which is thought to be the
the in vitro repair activity (not shown).consequence of the defect in TCR (Mayne and Lehmann,
1982; Troelstra et al., 1992). Microinjection of the anti-
CSA and anti-CSB (but not the pre-immune) antisera performed under physiological conditions, identical to
those in which in vitro activity assays are conducted.into repair-proficient fibroblasts significantly inhibited the
recovery of RNA synthesis after UV irradiation (Table I). Although denatured CSB has a molecular weight of 168
kDa, the CSB protein present in HeLa WCE chromato-This indicates that both antisera are capable of inhibiting
the function of CSA and CSB in vivo, and provides direct graphed at an estimated hydrodynamic size of 700 kDa
(Figure 5A), suggesting that it may be part of a proteinevidence for the involvement of these proteins in the TCR
and RNA synthesis recovery pathways. complex. Similar findings were made on Sephacryl S-300
and S-500 columns (data not shown). Furthermore, purifiedSimilarly, both antisera were injected into wild-type
fibroblasts to see whether inhibition of CS proteins has an functional recombinant CSB analysed in parallel did
behave very differently from the natural CSB in WCEseffect on overall RNA synthesis. However, no significant
difference was observed between injected and non-injected under various conditions (data not shown). The native
elution profile of other protein complexes, such as ERCC1/cells (Figure 3C, Table I), suggesting that neither CSA
nor CSB make a major contribution to transcription of XPF (majority running at a hydrodynamic size of 280 kDa)
and XPB (TFIIH) (500 kDa) (Figure 5A), and alsoundamaged cells in vivo.
To test whether CSB (and/or CSB-associated proteins) HHR23A (70 kDa) and HHR23B (140 kDa) (data not
shown), were as found before and in the expected sizeare required for repair and transcription in vitro, we
conducted immunodepletion experiments using repair- and range (Van Vuuren et al., 1995; Van der Spek et al.,
1996), making aspecific aggregation of proteins in thetranscription-competent HeLa whole cell extracts. As
shown in Figure 4, depletion of CSB performed under extract unlikely. The migration profile of RNA polymerase
II largely coincided with CSB (Figure 5A). These findingslow stringency conditions (upper panel) had no significant
effect on in vitro repair (middle panels) or basal transcrip- show that CSB in repair and transcription-competent
WCE migrates in a manner distinct from many othertion activities (lower panel). The latter finding is in
agreement with the microinjection experiments and con- NER factors.
Surprisingly, the 44 kDa CSA protein eluted at afirms that CSB is not essential for RNA synthesis. The
absence of a significant effect of CSB depletion on in vitro hydrodynamic size of 420 kDa, distinct from CSB (Figure
5B). Moreover, in the CS1AN-Sv extract (lacking CSB),NER is consistent with the notion that the in vitro NER
reaction mainly reflects transcription-independent NER. the same apparent size of CSA was found, strongly
suggesting that CSA is also part of a complex and thatThe above findings also imply that CSB in WCE is not
associated with critical quantities of essential NER and the major part of CSA is not stably associated with CSB
in these extracts.basal transcription factors, as detectable in in vitro assays.
To investigate the stability of the possible CSB complex,
Superdex fractionation was performed under different saltSuperdex gel filtration of HeLa whole cell extract
We next investigated whether or not CSB is complexed conditions. When the salt concentration was increased
from 0.1 to 0.5 and 1.0 M KCl, the apparent hydrodynamicwith other proteins by performing fractionations of repair-
and transcription-competent HeLa WCE (Figure 5) on size of CSB decreased from 700 kDa to ~500 and
450 kDa respectively, still considerably larger than thehydrodynamic volume. Superdex S-200 gel filtration was
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Fig. 6. CSB does not co-purify with the majority of the tested repair
and transcription proteins. (A) Elution fractions of the indicated
purification scheme were tested by immunoblot analysis for the
presence of CSB, CSA and XPG. The presence of functional ERCC1,
XPA, XPG and XPC was tested on immunoblots and by
microinjection and in vitro complementation (Van Vuuren et al., 1994,Fig. 5. CSB resides in a large molecular weight complex that does not
1995; A.P.M.Eker and W.Vermeulen, personal communication). Theinclude CSA. (A) Various WCEs were size-fractionated on a
purification of TFIIF, TFIIH, RNA polymerase II and otherSuperdex-200 column, loaded in the Manley-type buffer A containing
transcription proteins was described previously (Gerard et al., 1991).0.1 M KCl. Elution fractions were tested by immunoblotting using the
(B) HeLa WCE was fractionated on a phosphocellulose column byindicated antisera. The native sizes of molecular weight marker
loading in buffer A containing 0.15 M KCl, and eluting in buffer Aproteins, as well as the estimated sizes of the proteins tested, are
supplemented with KCl to 1.0 M. Elution fractions were tested byindicated. The WCE notated CS-B  2tCSB is derived from
immunoblot analysis for the presence of CSA and CSB, while theCS1AN-Sv fibroblasts transfected with double-tagged CSB (see
fractionation of the other proteins was described earlier (Shivji et al.,below). (B) The native size of CSA is unchanged by severe CSB
1992).truncation. Elution fractions of the Superdex-200 column, loaded with
either HeLa or CS1AN-Sv (CS-B) WCE were analysed using the
anti-CSA serum. The CSB gene in CS1AN-Sv cells contains a
premature stop mutation, leading to deletion of amino acid 337 to the subsequently in the DEAE 0.2 and 0.35 M KCl fraction
end (amino acid 1493) of the CSB protein (Troelstra et al., 1992). respectively, as tested by immunoblot (Figure 6A) and(C) The native size of CSB is dependent on salt concentration and
in vitro and in vivo complementation (A.J.van Vuuren andDNase pre-treatment. Equal amounts of HeLa WCE were loaded on
W.Vermeulen, unpublished observations). Surprisingly,the Superdex-200 column in buffer A containing respectively 0.1, 0.5
and 1.0 M KCl, or first treated with DNase and then loaded on the CSA eluted in the heparin 0.4 M fraction (and a trace at
column. Fractions were tested on immunoblots using anti-CSB 0.22 M), followed by elution in the DEAE 0.35 M KCl
antiserum. Elution of the molecular weight marker proteins was hardly
fraction, which is clearly distinct from CSB. Apart fromaffected by the altered salt conditions.
CSB, the heparin 1.0 M KCl fraction also contains the
XPC/HHR23B complex (Van der Spek et al., 1996) and,
interestingly, also TFIIF and RNA polymerase II (Gerarddenatured size of CSB and corresponding to the native
size of CSB after pre-treatment of the HeLa WCE with et al., 1991).
Next, we employed phosphocellulose column chromato-DNase (Figure 5C).
Taken together, these results suggest that in repair- and graphy, frequently used to separate NER core factors
(Shivji et al., 1992; Aboussekhra et al., 1995). The fractiontranscription-competent cell-free extracts CSB resides in
a protein complex, different from many NER proteins and that is not bound to the column at low salt (CF-I) contains
replication protein A (RPA) and proliferating cell nuclearcomplexes, that might be bound to DNA at low, but not
at high salt. antigen (PCNA), while the bound fraction (CF-II) contains
all other proteins required for in vitro NER (Shivji et al.,
1992). Remarkably, CSB is present exclusively in CF-II,Identification of CSB-co-purifying proteins
To determine the identity of the CSB-associated proteins, while all detectable CSA is present in CF-I (Figure 6B).
This again indicates that the majority of CSA and CSBfirst co-purification of any known repair and transcription
factors with CSB was investigated. For this, we assayed are not stably associated. More specifically, CSB elutes
between 0.4 and 0.6 M KCl (fraction FIII in Aboussekhrafractions of the purification scheme used to isolate basal
transcription factors and complexes required for RNA et al., 1995), excluding co-purification with the vast
majority of RPA, PCNA, XPG, XPA and ERCC1/XPFpolymerase II transcription (Gerard et al., 1991). On the
first column (heparin–Sepharose, Figure 6A), CSB eluted (data not shown).
In conclusion, in these fractionation schemes, CSB co-at 1.0 M KCl, excluding co-purification with TFIIA,
TFIIB, TFIID, TFIIH and the ERCC1/XPF complex fractionates with the XPC/HHR23B, TFIIF and RNA
polymerase II protein complexes, but not with the other(Gerard et al., 1991; Van Vuuren et al., 1995). The XPA
and XPG proteins eluted in the heparin 0.4 M and tested repair and basal transcription proteins. However,
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Using the HA epitope, we could completely immunopre-
cipitate the tagged CSB protein from a WCE of the
transfected CS1AN-Sv cells (Figure 7B, upper panel).
Since this was done under the same (low salt) buffer
conditions as the size fractionation, we expect that the
CSB-associating proteins are also bound to the beads.
Equal amounts of the original extract, the depleted extract
and an aliquot of the beads were tested on immunoblot
and probed with various antibodies (Figure 7B). Clearly,
no significant quantities of CSA, XPC, HHR23B, XPG,
TFIIH or TFIIF could be detected in the bound fraction
that contained all CSB. Similar results were obtained
when CSB was immunoprecipitated using the polyclonal
anti-CSB serum (data not shown). Since the latter serum
is raised against the C-terminus while the HA epitope is
Fig. 7. Function and immunoprecipitation of tagged CSB. (A) Tagging linked to the N-terminus of CSB, it is unlikely that binding
of CSB does not interfere with its cellular function. CS-B fibroblasts of antibody disrupts the interaction of CSB with the
were transfected with the indicated constructs, and the UV sensitivity proteins analysed. When CSA was immunoprecipitatedof mass populations was determined by UV irradiation and pulse
from HeLa cell-free extracts using the anti-CSA antiserum,labelling with [3H]TdR. u CS1AN-Sv (CS-B), d CS1AN-Sv 
antisense CSB, s CS1AN-Sv  sense CSB, e CS1AN-Sv  neither CSB nor XPG was co-immunoprecipitated (Figure
HA-CSB-His6 (2tCSB), j VH10-Sv (wild-type). (B) None of the 7C). This confirms the results above, and moreover indi-
tested candidate proteins co-immunoprecipitates with tagged CSB. cates the absence of significant quantities of stable CSA–
HA-/His6-double-tagged CSB was immunoprecipitated in buffer A XPG interactions in these extracts.from a WCE of UV-resistant CS1AN-Sv transformants using anti-HA
Interestingly, when RNA polymerase II was testedantibodies. The WCE, non-bound (n.b.) and bound (b.) proteins were
analysed on immunoblots with antisera specific for the indicated using antiserum against the largest subunit, a minor but
factors. Anti-XPB antibodies were used as representative of the TFIIH significant fraction (between 10 and 15%) appeared to be
complex; antisera against other components gave similar results (not bound to the beads that could be eluted under physiologicalshown). The RAP30 subunit of TFIIF gave the same result as the
conditions using competition with the synthetic HA epitopeRAP74 subunit (shown here). The asterisk indicates IgG bands.
(C) No detectable quantities of CSB or XPG co-immunoprecipitate (Figure 8A). Under the same conditions, no retention of
with CSA. The endogenous CSA protein from HeLa WCE was TFIIH (XPB subunit) or TFIIF (RAP74 subunit) could be
immunoprecipitated in buffer A using crude anti-CSA antiserum. The detected. The specificity of this binding is demonstrated
WCE, non-bound (n.b.) and bound (b.) proteins were tested on
further by the fact that when a similar co-immunoprecipit-immunoblot using the indicated antisera.
ation was performed using a HeLa WCE containing a
non-tagged version of CSB, no CSB or RNA polymerase
II could be recovered from the eluate (Figure 8B) orthe gel filtration studies described above suggest that the
composition of the possible CSB complex changes upon from the beads (data not shown). The binding of RNA
polymerase II to tagged CSB was found to be resistant toincreasing the salt concentration. Thus, the absence of co-
purifying proteins does not exclude weak interactions that high salt concentrations (Figure 8C), suggesting a direct
interaction of hydrophobic character. Moreover, when themay be disrupted due to the high salt and other harsh
conditions used for elution. immunoprecipitation reactions were supplemented with
ethidium bromide, that is known to disrupt protein–DNA
interactions without affecting protein–protein interactionsConstruction and immunoprecipitation of
HA-/His6-double-tagged CSB (Lai and Herr, 1992), similar amounts of RNA polymerase
II were found to be associated with CSB (Figure 8D).To investigate protein–protein interactions further and
to allow isolation of CSB-associating proteins under In conclusion, the combined results from the size
fractionation, co-purification and immunoprecipitationphysiological conditions, we generated CSB constructs
containing an N-terminal hemagglutinin antigen (HA) experiments suggest that CSB resides in a large molecular
weight protein complex that is devoid of detectableepitope as well as a C-terminal histidine (His6) tag (see
Materials and methods) and used monoclonal anti-HA amounts of CSA, XPA, XPB and XPD (TFIIH), XPC/
HHR23B, ERCC1/XPF, XPG, TFIIA, TFIIB, TFIID,antibodies for immunoprecipitation.
To verify that the addition of tags did not interfere with TFIIF, PCNA and RPA. In contrast, CSB seems to be
associated in a stable, DNA-independent manner with aCSB function, we transfected CS1AN-Sv cells with the
double-tagged CSB construct. Clearly, the cells transfected significant fraction of the RNA polymerase II molecules
in these protein extracts.with the HA-CSB-His6 cDNA showed a correction of UV
sensitivity to wild-type level, identical to the non-tagged
version (Figure 7A). Immunoblot analysis indicated that Discussion
the transfected cells contain amounts of tagged CSB
protein in the normal range, excluding significant over- Little is known about the molecular mechanism that acts
upon an elongating RNA polymerase II complex blockedexpression (Figure 1D). Also, the native size of tagged
CSB in a cell-free extract of these transfected cells is by a lesion. In the prokaryote Escherichia coli, a single
transcription–repair coupling factor (TRCF) was identifiedagain very large (700 kDa) (Figure 5A), indicating that
the tagged protein behaves in a similar way to the non- that is required and sufficient to mediate TCR in vitro
(Selby and Sancar, 1994). TRCF was shown to bind andtagged version in the cell.
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molecules, improper folding and lack of post-translational
modification or natural partners. Therefore, it is important
to verify interactions identified in such systems in vivo
under physiological conditions or by valid genetic means.
To approach the in vivo situation closely, we utilized
Manley-type WCEs to examine protein associations
involving CSB. These extracts have been used for purific-
ation of protein complexes and are active in in vitro repair,
transcription and splicing (Gerard et al., 1991; Wood
et al., 1995), indicating that they contain functional
multisubunit protein complexes. Indeed, we found evid-
ence that CSB resides in a large molecular weight complex
in such extracts. For analysis of complexes, it is important
to utilize conditions that leave delicate protein–protein
interactions as intact as possible. For this, we generated
a cell line that stably expresses double-tagged CSB protein,
Fig. 8. A fraction of RNA polymerase II is stably associated with and permits affinity purification using conditions under
tagged CSB. (A) RNA polymerase II is immunoprecipitated with which in vitro repair and transcription are known to takeHA-tagged CSB. Proteins that were bound to the HA affinity beads
place. We verified that the tags do not interfere with theafter immunoprecipitation of HA-/His6-double-tagged CSB from a
WCE of UV-resistant CS1AN-Sv transformants (2tCSB WCE) were CSB function (Figure 7A) and that the protein is not
eluted using the synthetic peptide of the HA epitope. The WCE, overexpressed (Figure 1D). Using similarly tagged TFIIH
non-bound (n.b.) and eluted proteins (HA elution) were tested on an subunits, we recently have found that the HA affinityimmunoblot as indicated. (B) Binding of RNA polymerase II to
step yields a very high (10 000-fold) purification (G.S.HA affinity resin is specific for tagged CSB. A similar
Winkler, G.Weeda and J.H.J.Hoeijmakers, in preparation).immunoprecipitation as in (A) was performed on a HeLa WCE that
contains a non-tagged CSB protein. (C) The interaction between CSB This implies that co-retention on the affinity column is
and RNA polymerase II is resistant to high salt concentrations. highly specific. Our studies yielded several unexpected
Following immunoprecipitation of HA-tagged CSB from the 2tCSB results.WCE, beads with bound proteins were either boiled and analysed on
Since we showed that TCR and recovery of RNAimmunoblot (b.), or incubated in buffer A with increasing amounts of
KCl. Elution fractions containing 0.3, 0.6 or 1.0 M KCl (lanes 1, 2 synthesis after UV in living human cells requires both CS
and 3 respectively), as well as the boiled beads after salt incubation proteins (Table I), we anticipated these products to be
(b.*) were analysed on immunoblot as indicated. (D) CSB and RNA stably associated with each other. However, unexpectedly,polymerase II do not interact via DNA. Immunoprecipitation of tagged
CSA and CSB were found to be part of different com-CSB from the 2tCSB WCE was performed in the presence of ethidium
plexes. (i) Superdex gel filtration indicated that theybromide (EtdBr) at 50 mg/ml. Subsequently, the WCE, non-bound
(n.b.) and bound (b.) proteins were tested on immunoblot. migrate with a different hydrodynamic size. (ii) CSA
and CSB fractionate differently on both heparin and
phosphocellulose. The latter recently was also found indisplace a stalled RNA polymerase and, by recruiting the
damage recognition protein UvrA, to stimulate repair an independent study (Selby and Sancar, 1997). (iii) When
immunoprecipitating CSA or CSB from different extracts(Selby and Sancar, 1995). In eukaryotes, the TCR reaction
is probably much more complex and, hitherto, all efforts using tags and various antibodies, no stable association
was detected. However, binding of in vitro translated CSAto reconstruct this system in vitro have failed. Even the
composition of a paused transcription elongation complex and CSB proteins to each other was found recently while
an interaction in the two-hybrid system was mentionedis still largely unknown. Previously, cellular studies have
suggested a specific role for the CSA and B proteins in (Henning et al., 1995), indicating that under certain
conditions these proteins are able to interact.TCR (Venema et al., 1990a; Van Hoffen et al., 1993).
However, the clinical hallmarks of CS suggest that, in The dual role of TFIIH in repair and transcription led
to the suggestion that TFIIH also plays a central role inaddition to TCR, the transcription process itself may also
be affected (Vermeulen et al., 1994; Hoeijmakers et al., TCR (Schaeffer et al., 1993; Drapkin et al., 1994). In
addition, since patients carrying mutations in the CS genes1996; Van Gool et al., 1997). Here we partially character-
ized the function of CSB by in vivo microinjection of and in the XPB and XPD subunits of TFIIH display
comparable clinical features, it has been suggested thatantisera, in vitro immunodepletions and analysis of
protein–protein interactions. the CSA and CSBmutations interfere with the transcription
mode of TFIIH (Drapkin et al., 1994; Vermeulen et al.,
1994; Van Oosterwijk et al., 1996). However, in theIdentification of proteins interacting with CSB
Manymethods used to identify protein–protein interactions analysis presented here, we failed to detect any stable
association of CSB with TFIIH subunits in column frac-employ overexpressed, in vitro synthesized or purified
(parts of) proteins, often involving heterologous systems. tionations and immunoprecipitations, performed under
conditions that leave the TFIIH complex intact. In aOne of the potential caveats in these approaches derives
from the fact that the protein is studied outside of its reciprocal experiment, in which the TFIIH complex was
immunoprecipitated from Manley-type WCEs as well asnatural context. Particularly, when the protein in vivo
resides in a complex with multiple interaction domains, it from nuclear extracts using an HA-tagged XPB subunit,
again no indication for an association with CSB wasmay exhibit artificial association behaviour when
examined in isolation. Moreover, overexpression may lead found (G.S.Winkler, G.Weeda and J.H.J.Hoeijmakers, in
preparation). In addition, no interaction between the yeastto incomplete synthesis or degradation of a fraction of the
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homologue of CSB, Rad26p, and yeast TFIIH could be involvement. It will be important to establish which form
of RNA polymerase is complexed with CSB. At present,observed (Guzder et al., 1996). However, recently, a resin
several distinct RNA polymerase II-containing complexescontaining a GST–CSB (ATPase domain) fusion protein
have been identified in eukaryotes (Kim et al., 1994;was shown to retain XPB from cell-free extracts (Selby
Koleske and Young, 1994; Ossipow et al., 1995;and Sancar, 1997).
Maldonado et al., 1996; Shi et al., 1997). Generally, theyA number of XP-G patients display characteristic CS
entail pre-assembled transcription initiation complexesfeatures (Vermeulen et al., 1993), possibly reflecting a
that mediate activation of a subset of genes in responsedisturbed XPG–CSB interaction. We have tried to detect
to transcriptional activators. Forms of RNA polymeraseinteractions between in vitro translated, full-length XPG
II engaged in transcription elongation or terminationand CSB proteins by co-immunoprecipitations under
are poorly characterized. When the CSB complex wasvarious conditions, but failed to detect any association of
immunodepleted, no significant effect on in vitro basalsignificant quantities of either protein (data not shown).
transcription was found, despite the fact that a fraction ofAlso, the analysis in cell-free extracts presented here does
RNA polymerase II was found to be complexed to CSB.not indicate any (stable) association between XPG and Several explanations can be considered. (i) The fractionCSB: (i) XPG fractionates differently on heparin (Figure of RNA polymerase II co-depleted, estimated to be
6A) and phosphocellulose (data not shown); (ii) XPG between 10 and 15%, is too small to exert a detectable
does not co-immunoprecipitate with CSB using the anti- effect in the in vitro assay. Normally RNA polymerase
HA monoclonal antibody (Figure 7B) or using the crude is not the rate-limiting factor (J.-M.Egly, unpublished
anti-CSB serum (not shown); and (iii) no co-immunopre- observation). (ii). This form of RNA polymerase II is not
cipitation of CSB with XPG is observed using a crude detectable in the in vitro transcription system. Our finding
anti-XPG serum (not shown). In contrast to our results, that none of the transcription initiation factors are co-
binding of an in vitro translated XPG protein to unlabelled, immunoselected with tagged CSB argues that CSB does
in vitro translated CSB was reported recently (Iyer not interact with RNA polymerase molecules engaged in
et al., 1996). transcription initiation, and is consistent with the idea that
The heparin column chromatography (Figure 6A) indi- the protein may be part of an elongating type of RNA
cated co-fractionation of CSB with the XPC/HHR23B polymerase complex. Furthermore, when antisera against
complex, involved in global genome repair (Venema et al., CSB (and CSA) are microinjected in living cells, we
clearly observed inhibition of TCR and recovery of RNA1990b; Masutani et al., 1994). CSB and XPC/HHR23B
synthesis after UV, while no significant decrease in basalare involved in complementary repair pathways and, as
transcription levels was noted. In contrast, microinjectionscould be expected, were found not to be stably associated
of antisera against TFIIH components resulted in a drastic(Figure 7B).
decrease in transcription levels (Van Vuuren et al., 1994;Transcription initiation/elongation factor TFIIF and
Marinoni et al., 1997). These results imply that CSBRNA polymerase II are present in the heparin 1.0 M
does not have a major contribution to the normal basalfraction. Both factors play an important role in transcrip-
transcription process. This does not rule out, however,tion elongation: RNA polymerase evidently is the core of
the possibility that CSB modulates the efficiency ofthe elongation machinery, while TFIIF is reported to
transcription in a more subtle manner, and as a secondincrease elongation efficiency by suppressing the time an
function mediates TCR. As suggested above, CSB mightRNA polymerase molecule pauses at intrinsic pause sites
function as an elongation factor that is able to release a(Aso et al., 1995). TFIIF was not co-immunoprecipitated
trapped transcription complex and thus stimulate transcrip-detectably with tagged CSB (Figures 7 and 8), but a
tion efficiency, while not being essential for this processsignificant portion of RNA polymerase II was (Figure 8). (discussed further in Van Gool et al., 1997). Release ofThis interaction was shown to be specific for CSB, resistant the stalled elongating RNA polymerase may involve its
to high salt, and not mediated via DNA. Recently, we ubiquitination, that recently was shown to occur after
found that the CSB-bound RNA polymerase II is fully genotoxic treatment of cells, and to depend on the CSA
functional in a reconstitued in vitro transcription reaction, and CSB gene products (Bregman et al., 1996). It should
implying that it is functionally intact. be noted that our extracts are made from undamaged cells,
In conclusion, in Manley-type WCEs, CSB appears to which are therefore not expected to perform high rates
reside in a large complex that includes RNA polymerase of NER. The analysis of extracts from damaged cells
II but none of the other core repair and transcription performing maximal TCR that could reveal other protein
proteins investigated. Obviously, our studies do not pre- interactions is in progress. A multiprotein complex
clude transient interactions that may occur in the course that specifically associates with RNA polymerase in the
of the TCR reaction or very fragile complexes that are elongating phase recently has been isolated from yeast
disrupted during the preparation of the extracts. This may (J.Svejstrup, personal communication). It will be of interest
explain the interactions found using other methods for to know whether a similar complex exists in human cells
and, if so, whether CSB is involved. Finally, the presencedetection of protein–protein binding in the studies cited
of CSB in an RNA polymerase II complex is consistentabove.
with the idea that CS is in part due to impaired tran-
scription.The contribution of CSB to transcriptional
regulation
Materials and methodsThe stable association of CSB with RNA polymerase II
described in this study supports the hypothesis that CSB
Cell lines and extracts
is involved in transcription as well. However, at this The immortalized cell lines used in this study were HeLa, VH10-Sv
(wild-type), CS1AN-Sv (CS-B), CS3BE-Sv (CS-A), CW12 (XP-A),stage, one can only speculate about the nature of this
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XPCS1BA-Sv (XP-B), XP4PA-Sv (XP-C), HD2 (XP-D), XP2YO-Sv were loaded on a Superdex-200 column (SMART system, Pharmacia)
that was first calibrated using the molecular markers thyroglobulin(XP-F), XP3BR-Sv (XP-G) and TTD1BR-Sv [trichothiodystrophy A
(TTD-A)]. The fibroblasts were cultured in a 1:1 mixture of Ham’s F10 (669 kDa), ferritin (440 kDa), catalase (240 kDa) and albumin (67 kDa).
Chromatography was performed in buffer A, containing 0.1, 0.5 orand Dulbecco’s modified Eagle’s medium (DMEM), supplemented with
antibiotics and 8–10% fetal calf serum. WCEs were prepared according 1.0 M KCl. Fractions were collected and tested on immunoblots as
described above. DNase pre-treatment of the HeLa WCE was performedto Manley et al. (1983) as modified by Wood et al. (1995), dialysed
against buffer A containing 25 mM HEPES/KOH pH 7.8, 100 mM KCl, by incubating 1 mg of WCE with 10 μl (10 μg/μl) DNase for 10 min
at 37°C. Complete digestion of all DNA was verified by agarose gel12 mM MgCl2, 1 mM EDTA, 2 mM dithiothreitol (DTT) and 17%
(v/v) glycerol, and stored at –80°C. The protein concentration of these electrophoresis.
WCEs was 15–20 mg/ml.
Column fractionations
Antibodies and immunoblot procedures Fractions of the heparin column were obtained as previously described
Rabbit polyclonal anti-CSB antibodies were raised against the C-terminal (Gerard et al., 1991). In short, HeLa WCE was loaded on a heparin–
158 amino acids of CSB, overproduced as a protein A fusion product Ultrogel column in buffer A and eluted with 0.22, 0.4 and 1.0 M KCl,
in Escherichia coli using standard protocols (Harlow and Lane, 1988). while the heparin 0.4 M KCl fraction was fractionated further on
Affinity purification was done using immunoblots of a purified GST a DEAE–Spherodex column by elution with 0.2 and 0.35 M KCl.
fusion protein containing the same C-terminal region of CSB, and elution Phosphocellulose column chromatography was performed as described
using a KSCN buffer [0.1 M KPi pH 7.0, 3 M KSCN, 1 mg/ml bovine (Shivji et al., 1992) by loading the HeLa WCE on a phosphocellulose
serum albumin (BSA)]. The CSA cDNA (Henning et al., 1995) was column in buffer A, supplemented with KCl to 0.15 M. The bound
isolated via RT–PCR from human granulocyte RNA. Rabbit polyclonal proteins were eluted in buffer A containing 1.0 M KCl. Fractions were
anti-CSA antibodies were raised against the C-terminal half of the CSA analysed on immunoblot as described above.
protein (encoding amino acids 176–396), overproduced as a GST fusion
product in E.coli. Affinity-purified anti-CSA antibodies were obtained Generation of tagged CSB constructs
by incubation of the crude serum with immunoblot strips containing HA and His6-tagged CSB constructs were generated to facilitate immuno-
purified GST–CSA fusion protein, followed by elution with acidic precipitation and allow isolation of CSB-associating proteins. The
glycine buffer (0.1 M glycine pH 1.0, 0.5 M NaCl, 0.5 mg/ml BSA). N-terminal HA epitope was introduced via PCR using the CSB cDNA,
The generation and characterization of the polyclonal anti-ERCC1 (Van the sense primer 5 CATCGAGCTCATGTACCCATACGATGTTCCA-
Vuuren et al., 1993), anti-XPG (O’Donovan and Wood, 1993) and GATTACGCTAGCCCAAATGAGGGAATCCCC 3 [encoding a SacI
monoclonal anti-p89/XPB (Schaeffer et al., 1993) antibodies have been restriction site (underlined), start codon, HA epitope (double underlined)
described before. and CSB cDNA bp 4–21] and the antisense primer EC179-2, 5
To visualize large molecular weight proteins such as CSB (168 kDa) CTCTGGCCTCATGTCTGACTCCCA 3 (CSB cDNA bp 1062–1085).
on immunoblot, proteins were transferred to PVDF or nitrocellulose After DNA sequencing to check for the absence of PCR-generated
membrane by blotting for 2–3 h at 4°C in blot buffer without methanol mutations, a SacI fragment containing the HA-tagged N-terminus of
(25 mM Tris–HCl pH 8.3, 0.2 M glycine) with the addition of SDS to CSB was exchanged with the corresponding SacI fragment in the CSB
0.01%. After blocking, the blot was incubated overnight with crude cDNA. In a similar way, a stretch of six histidines was linked to the
(1:500) or affinity-purified (1:400) anti-CSB serum, followed by nitroblue C-terminal end of CSB. For PCR amplification, the sense primer
tetrazolium/5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP) detec- EC179-5, 5 GTGAAACAAGAGTGAGGCCAAGG 3 (CSB cDNA
tion. For other proteins, the standard procedure for immunoblotting was bp 3705–3729), and the antisense primer 5 CTGGGGCCCTTAGTGAT-
followed (Harlow and Lane, 1988). GGTGATGGTGGTGACGACCTTCGATGCAGTATTCTGGCTTGAG
3 [encoding CSB cDNA bp 4460–4477, a factor Xa cleavage site, theImmunofluorescence His6 stretch (double underlined), ochre stop codon and an ApaI restrictionHeLa and CS1AN-Sv cells were grown on slides, washed with phosphate- site (underlined)] were used. The His6-tagged CSB C-terminus wasbuffered saline (PBS), fixed by incubation in 2% paraformaldehyde– isolated after ApaI digestion and exchanged with the correspondingPBS for 10 min and permeabilized in methanol for 20 min. Slides were region in the CSB cDNA.washed three times in PBS (PBS, 0.15% glycine, 0.5% BSA) and
incubated with affinity-purified anti-CSB (1:5 dilution) for 1.5 h in a DNA transfections and UV survivalmoist chamber. After washing in PBS, slides were incubated with CS1AN-Sv fibroblasts were transfected with pSLME6(–) (antisensefluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit antiserum
CSB), pSLME6() (sense CSB) or pSLM2tE6 (HA-CSB-His6), togetherat a 1:80 dilution for 1.5 h. Slides were washed and embedded in with the selectable marker pSV2-neo using a modification of thevectashield mounting medium (Brunschwig) that contained 4-6-diamino- calcium phosphate precipitation method (Graham and van der Eb, 1973).2-phenylindole (DAPI). DAPI-stained DNA and FITC-labelled CSB was Following G418 selection, cells were split and selected for UV resistancevisualized using fluorescence microscopy. by three daily irradiations with 4 J/m2 UV-C (254 nm). UV-selected
mass populations of CS1AN-Sv  pSLME6() and CS1AN-Sv Microneedle injection of antisera and analysis of repair and
pSLM2tE6 and non-UV-selected mass populations of CS1AN-Sv,transcription levels
CS1AN-Sv pSLME6(–) and VH10-Sv cells were characterized furtherMicroinjection of immune sera into cultured fibroblasts was performed
by UV survival. For this, cells were plated (2105 per 3 cm dish, 2–4as described previously (Van Vuuren et al., 1994). The anti-CSA and
dishes per dose) and exposed to 0, 2, 4 or 7 J/m2 UV 1 day afteranti-CSB antisera were microinjected into the cytoplasm of wild-type
plating. Survival was determined after 4–6 days incubation at 37°C by(C5RO) or XP-C (XP21RO) fibroblasts. After microinjection, cells were
[3H]thymidine pulse labelling as described elsewhere (Sijbers et al.,incubated further for 24 h at 37°C in standard medium to allow antibody–
1996b).antigen reaction. The effect on NER activity by microinjection of the
antisera in XP-C fibroblasts (represented by UV-induced UDS) was
In vitro translation and immunoprecipitationsdetermined by UV irradiation of the cells (254 nm; 15 J/m2), pulse
In vitro translated CSB and CSA protein were synthesized using thelabelling for 2 h using [3H]thymidine (60 μCi/ml, sp. act. 120 Ci/mmol),
TNT T7 Coupled Reticulocyte Lysate System (Promega) as describedfixation and in situ autoradiography. Grains above the nuclei of injected
by the manufacturer. The in vitro translated CSB protein was immunopre-(polykaryon) and non-injected (monokaryon) cells were counted and
cipitated in a standard manner in NETT buffer (100 mM NaCl, 5 mMcompared. Levels of RNA synthesis after microinjection in wild-type
EDTA, 50 mM Tris–HCl pH 7.5, 0.5% Triton X-100) using crude anti-cells were analysed by pulse labelling with [3H]uridine (10 μCi/ml; sp.
CSB serum. Immunoprecipitation of endogenous CSB or CSA fromact. 50 Ci/mmol) for 1 h in standard medium, and further processing as
HeLa WCEs was achieved by first incubating crude antiserum withmentioned above. The recovery of RNA synthesis post-UV was assayed
protein A–Sepharose beads (Pharmacia) in PBS–Tween (0.5%) for 1–by microinjecting the antisera in wild-type cells, followed by a further
2 h at 4°C, followed by extensive washing (twice with PBS–Tween andincubation for 8 h at 37°C. Then, the cells were UV irradiated (254 nm;
four times with buffer A) and a further incubation of the antiserum-10 J/m2) and, 24 h later, RNA synthesis was determined by [3H]uridine
coated protein A beads with 1 mg of HeLa WCE for 5 h at 4°C. Thepulse labelling as described above.
immunodepleted HeLa extract was recovered from the beads by spinning
and analysed in activity assays or on immunoblot, together with theSuperdex gel filtration
To fractionate proteins and protein complexes on the basis of size and/ proteins bound to the beads. Immunoprecipitation of HA-CSB-His6 was
done by incubating the monoclonal anti-HA antibody 12CA5 overnightor shape (hydrodynamic volume), HeLa or CS1AN-Sv WCEs (1 mg)
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at 4°C with a WCE of the CS1AN-Sv cells transfected with the Egly,J.-M. (1991) Purification and interaction properties of the human
double-tagged CSB construct, followed by addition of protein G beads RNA polymerase B(II) general transcription factor BTF2. J. Biol.
(Pharmacia) and further incubation for 5 h at 4°C. Together with the Chem., 266, 20940–20945.
depleted extract, bound proteins were analysed by SDS–PAGE and Graham,F.L. and van der Eb,A. (1973) A new technique for the assay
immunoblotting after boiling the beads. Alternatively, bound proteins of infectivity of human adenovirus 5 DNA. Virology, 52, 456–467.
were eluted by incubation with a synthetic peptide encoding the HA Guzder,S.N., Habraken,Y., Sung,P., Prakash,L. and Prakash,S. (1996)
epitope (1 mg/ml) overnight at 4°C. Rad26, the yeast homolog of human Cockayne’s syndrome group
B gene, encodes a DNA-dependent ATPase. J. Biol. Chem., 271,
In vitro repair and transcription assays 18314–18317.
Analysis of in vitro repair activity was performed as described in detail Hanawalt,P.C. (1992) Transcription-dependent and transcription-coupled
before (Wood et al., 1995), by mixing 100 μg of (depleted) cell-free DNA repair responses. Alfred Benzon Symp., 35, 231–242.
extract with a mixture of AAF-modified and non-damaged plasmids Hanawalt,P.C., Donahue,B.A. and Sweder,K.S. (1994) Collision or
(Van Vuuren et al., 1993). Repair activity, i.e. incorporation of collusion? Curr. Biol., 4, 518–521.
[α-32P]dATP into the damaged plasmid, was visualized by autoradio- Harlow,E. and Lane,D. (1988) Antibodies: A Laboratory Manual. Cold
graphy.
Spring Harbor Laboratory Press, Cold Spring Harbor, NY.In vitro transcription activity was assayed as described before (Gerard
Henning,K.A. et al. (1995) The Cockayne syndrome group A geneet al., 1991), by incubating 100 μg of (depleted) cell-free extract with
encodes a WD repeat protein that interacts with CSB protein and aan Ad2MLP promoter-containing template, together with the required
subunit of RNA polymerase II TFIIH. Cell, 82, 555–564.nucleotides. The 309 nucleotide [α-32P]CTP-labelled run-off transcripts
Hoeijmakers,J.H.J. (1994) Human nucleotide excision repair syndromes:were visualized using autoradiography.
molecular clues to unexpected intricacies. Eur. J. Cancer, 30A,
1912–1921.
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